ISSN 1673-3770 CN 37-1437/R
Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2026, Vol. 40 ›› Issue (2): 125-132.doi: 10.6040/j.issn.1673-3770.0.2024.125
• Review • Previous Articles
NING Yuyun1, LI Tong2, ZHANG Xinxin3
CLC Number:
| [1] Liu S, Yang G, Li QN, et al. Safety and efficacy of topical diquafosol for the treatment of dry eye disease: an updated meta-analysis of randomized controlled trials[J]. Indian Journal of Ophthalmology, 2023, 71(4): 1304-1315. doi:10.4103/IJO.IJO_268_23 [2] 亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组. 中国干眼专家共识: 治疗(2020年)[J]. 中华眼科杂志, 2020, 56(12): 907-913. doi:10.3760/cma.j.cn112142-20200925-00618 [3] Sheppard JD, Nichols KK. Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape[J]. Ophthalmology and Therapy, 2023, 12(3): 1397-1418. doi:10.1007/s40123-023-00669-1 [4] Rolando M, Zierhut M, Barabino S. Should we reconsider the classification of patients with dry eye disease [J]. Ocular Immunology and Inflammation, 2021, 29(3): 521-523. doi:10.1080/09273948.2019.1682618 [5] Rolando M, Merayo-lloves J. Management strategies for evaporative dry eye disease and future perspective[J]. Current Eye Research, 2022, 47(6): 813-823. doi:10.1080/02713683.2022.2039205 [6] Lam SM, Tong L, Duan XR, et al. Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles[J]. Journal of Lipid Research, 2014, 55(2): 289-298. doi:10.1194/jlr.M044826 [7] Agarwal P, Craig JP, Rupenthal ID. Formulation considerations for the management of dry eye disease[J]. Pharmaceutics, 2021, 13(2): 207. doi:10.3390/pharmaceutics13020207 [8] Khanal S, Bai YQ, Nao W, et al. Human meibum and tear film derived cholesteryl and wax esters in meibomian gland dysfunction and tear film structure[J]. The Ocular Surface, 2022, 23: 12-23. doi:10.1016/j.jtos.2021.10.009 [9] 蒋冬冬, 靳荷. 睑板腺功能障碍相关干眼的诊疗进展[J]. 国际眼科杂志, 2021, 21(7): 1209-1212. doi:10.3980/j.issn.1672-5123.2021.7.16 [10] Gurlevik U, Karakoyua A, Yasar E. Does Sjogren's syndrome affect only the lacrimal gland in the eye Time to replace the missing stones[J]. Indian Journal of Ophthalmology, 2021, 69(1): 53-57. doi:10.4103/ijo.IJO_2383_19 [11] Chhadva P, Goldhardt R, Galor A. Meibomian gland disease the role of gland dysfunction in dry eye disease[J]. Ophthalmology, 2017, 124(11): S20-S26. doi:10.1016/j.ophtha.2017.05.031 [12] 李威, 张斌. 优化脉冲光联合睑板腺按摩治疗睑板腺功能障碍的临床效果观察[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 105-109. doi:10.6040/j.issn.1673-3770.0.2020.341 [13] 亚洲干眼协会中国分会, 海峡两岸医药卫生交流协会眼科学专业委员会眼表与泪液病学组, 中国医师协会眼科医师分会眼表与干眼学组.中国睑板腺功能障碍专家共识:定义和分类(2023年)[J]. 中华眼科杂志, 2023, 59(4): 256-261. doi:10.3760/cma.j.cn112142-20230114-00023. [14] 狄宇. 干眼炎症反应机制及抗炎治疗的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 144-150. doi:10.6040/j.issn.1673-3770.0.2020.484 [15] Holland EJ, Jackson MA, Donnenfeld E, et al. Efficacy of lifitegrast ophthalmic solution, 5.0%, in patients with moderate to severe dry eye disease: a post hoc analysis of 2 randomized clinical trials[J]. JAMA Ophthalmology, 2021, 139(11): 1200-1208. doi:10.1001/jamaophthalmol.2021.3943 [16] Malmin A, Thomseth VM, Frland PT, et al. Associations between serial intravitreal injections and dry eye[J]. Ophthalmology, 2023, 130(5): 509-515. doi:10.1016/j.ophtha.2023.01.009 [17] Capasso L, Abbinante G, Coppola A, et al. Recent evidence of tea tree oil effectiveness in blepharitis treatment[J]. BioMed Research International, 2022, 2022(1): 9204251. doi:10.1155/2022/9204251 [18] Jacobi C, Doan S, Pavel V, et al. Different approach to Manage Demodex Blepharitis-initial and maintenance treatment[J]. Current Eye Research, 2022, 47(3): 352-360. doi:10.1080/02713683.2021.1978099 [19] Liu WT, Gong L. Anti-demodectic effects of okra eyelid patch in Demodex blepharitis compared with tea tree oil[J]. Experimental and Therapeutic Medicine, 2021, 21(4): 338. doi:10.3892/etm.2021.9769 [20] Navel V, Mullez A, Benoist d'Azy C, et al. Efficacy of treatments for demodex blepharitis: a systematic review and meta-analysis[J]. The Ocular Surface, 2019, 17(4): 655-669. doi:10.1016/j.jtos.2019.06.004 [21] Sabeti S, Kheirkhah A, Yin J, et al. Management of meibomian gland dysfunction: a review[J]. Survey of Ophthalmology, 2020, 65(2): 205-217. doi:10.1016/j.survophthal.2019.08.007 [22] Stroman DW, Mintun K, Epstein AB, et al. Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin[J]. Clin Ophthalmol, 2017, 11: 707-714. doi:10.2147/opth.s132851 [23] Correia S, Poeta P, Hébraud M, et al. Mechanisms of quinolone action and resistance: where do we stand [J]. Journal of Medical Microbiology, 2017, 66(5): 551-559. doi:10.1099/jmm.0.000475 [24] 许海嘉, 李蓓, 范罕英, 等. 药物联合物理疗法治疗MGD所致干眼的疗效观察[J]. 国际眼科杂志, 2019, 19(10): 1787-1790. doi:10.3980/j.issn.1672-5123.2019.10.36 [25] 孙圣书, 黄悦. 抗生素治疗睑板腺功能障碍的研究进展[J]. 国际眼科杂志, 2022, 22(5): 827-832. doi:10.3980/j.issn.1672-5123.2022.5.26 [26] Mah FS, Karpecki PM. Review of loteprednol etabonate 0.5%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis[J]. Ophthalmology and Therapy, 2021, 10(4): 859-875. doi:10.1007/s40123-021-00401-x [27] 胡晓娟, 卢丽丽, 刘猛. 睑板腺按摩联合抗生素滴眼液治疗睑板腺功能障碍性干眼的效果[J]. 医学信息, 2020, 33(14): 76-79. doi:10.3969/j.issn.1006-1959.2020.14.022 [28] Jerkins G, Greiner JV, Tong L, et al. A comparison of efficacy and safety of two lipid-based lubricant eye drops for the management of evaporative dry eye disease[J]. Clinical Ophthalmology, 2020, 14: 1665-1673. doi:10.2147/OPTH.S256351 [29] Chan TCY, Chow SSW, Wan KHN, et al. Update on the association between dry eye disease and meibomian gland dysfunction[J]. Medical Journal, 2019, 25(1): 38-47. doi:10.12809/hkmj187331 [30] Labetoulle M, Benitez-del-castillo JM, BARABINO S, et al. Artificial tears: biological role of their ingredients in the management of dry eye disease[J]. International Journal of Molecular Sciences, 2022, 23(5): 2434. doi:10.3390/ijms23052434 [31] 陆菁, 刘辰, 吴晋晖, 等. 人工泪液成分的最新研究及进展[J]. 中南药学, 2022, 20(11): 2635-2641. doi:10.7539/j.issn.1672-2981.2022.11.031 [32] Li Y, Cui L, Lee HS, et al. Comparison of 0.3% hypotonic and isotonic sodium hyaluronate eye drops in the treatment of experimental dry eye[J]. Current Eye Research, 2017, 42(8): 1108-1114. doi:10.1080/02713683.2017.1297462 [33] Liu Z, Chen D, Chen X, et al. Trehalose induces autophagy against inflammation by activating TFEB signaling pathway in human corneal epithelial cells exposed to hyperosmotic stress[J]. Investigative Ophthalmology & Visual Science, 2020, 61(10): 26. doi:10.1167/iovs.61.10.26 [34] Goldstein MH, Silva FQ, Blender N, et al. Ocular benzalkonium chloride exposure: problems and solutions[J]. Eye(London, England), 2022, 36(2): 361-368. doi:10.1038/s41433-021-01668-x [35] Kallab M, Szegedi S, Hommer N, et al. Correction to: topical low dose preservative-free hydrocortisone reduces signs and symptoms in patients with chronic dry eye: a randomized clinical trial[J]. Advances in Therapy, 2020, 37(1): 342-343. doi:10.1007/s12325-019-01190-3 [36] Prinz J, Maffulli N, Fuest M, et al. Efficacy of topical administration of corticosteroids for the management of dry eye disease: systematic review and meta-analysis[J]. Life, 2022, 12(11): 1932. doi:10.3390/life12111932 [37] Messmer EM, Ahmad S, Del Castillo JMB, et al. Management of inflammation in dry eye disease: recommendations from a European panel of experts[J]. European Journal of Ophthalmology, 2023, 33(3): 1294-1307. doi:10.1177/11206721221141481 [38] Boboridis KG, Konstas AGP. Evaluating the novel application of cyclosporine 0.1% in ocular surface disease[J]. Expert Opinion on Pharmacotherapy, 2018, 19(9): 1027-1039. doi:10.1080/14656566.2018.1479742 [39] Rhim JW, Eom Y, Yoon EG, et al. Efficacy of a 0.05% cyclosporine a topical nanoemulsion in dry eyes with obstructive meibomian gland dysfunction[J]. Japanese Journal of Ophthalmology, 2022, 66(3): 254-263. doi:10.1007/s10384-022-00906-3 [40] Tauber J. A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction[J]. Cornea, 2020, 39(4): 403-407. doi:10.1097/ICO.0000000000002235 [41] Donnenfeld ED, Karpecki PM, Majmudar PA, et al. Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease: a 1-year, multicenter, randomized, placebo-controlled study[J]. Cornea, 2016, 35(6): 741-748. doi:10.1097/ICO.0000000000000803 [42] Jain K, Jaju M, Yadav D. Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre[J]. Indian Journal of Ophthalmology, 2023, 71(4): 1598-1602. doi:10.4103/IJO.IJO_2586_22 [43] Fukuoka S, Arita R. Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study[J]. Scientific Reports, 2019, 9(1): 9091. doi:10.1038/s41598-019-45475-7 [44] Katagiri A, Tsubota K, Mikuzuki L, et al. Diquafosol sodium reduces neuronal activity in trigeminal subnucleus caudalis in a rat model of chronic dry eye disease[J]. Neuroscience Letters, 2023, 792: 136939. doi:10.1016/j.neulet.2022.136939 [45] 刘子彬, 张蕊, 李能, 等. 3%地夸磷索钠滴眼液治疗睑板腺功能障碍相关性干眼[J]. 国际眼科杂志, 2022, 22(8): 1271-1276. doi:10.3980/j.issn.1672-5123.2022.8.07 [46] Wang LX, Deng YP. Androgen and meibomian gland dysfunction: from basic molecular biology to clinical applications[J]. International Journal of Ophthalmology, 2021, 14(6): 915-922. doi:10.18240/ijo.2021.06.18 [47] Goleiowski B, Badarudin N, Eden J, et al. The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: a randomised, placebo-controlled, pilot study[J]. British Journal of Ophthalmology, 2017, 101(7): 926-932. doi:10.1136/bjophthalmol-2016-309498 [48] Ibrahim MAA, Elwan WM. Role of topical dehydroepiandrosterone in ameliorating isotretinoin-induced Meibomian gland dysfunction in adult male albino rat[J]. Annals of Anatomy - Anatomischer Anzeiger, 2017, 211: 78-87. doi:10.1016/j.aanat.2017.01.007 [49] Stolowich N, Vittitow J, Kissling R, et al. Oxygen-carrying capacity of perfluorohexyloctane, a novel eye drop for dry eye disease[J]. Current Therapeutic Research, 2023, 98: 100705. doi:10.1016/j.curtheres.2023.100705 [50] Tauber J, Berdy GJ, Wirta DL, et al. NOV03 for dry eye disease associated with meibomian gland dysfunction results of the randomized phase 3 GOBI study[J]. Ophthalmology, 2023, 130(5): 516-524. doi:10.1016/j.ophtha.2022.12.021 [51] Delicado-Miralles M, Velasco E, Díaz-Tahoces A, et al. Deciphering the action of perfluorohexyloctane eye drops to reduce ocular discomfort and pain[J]. Frontiers in Medicine, 2021, 8: 709712. doi:10.3389/fmed.2021.709712 [52] Vittitow J, Kissling R, Decory H, et al. In vitro inhibition of evaporation with perfluorohexyloctane, an eye drop for dry eye disease[J]. Current Therapeutic Research, 2023, 98: 100704. doi:10.1016/j.curtheres.2023.100704 [53] Tian L, Gao ZJ, Zhu L, et al. Perfluorohexyloctane eye drops for dry eye disease associated with meibomian gland dysfunction in Chinese patients: a randomized clinical trial[J]. JAMA Ophthalmology, 2023, 141(4): 385-392. doi:10.1001/jamaophthalmol.2023.0270 |
| [1] | LI Yuchen, WANG Xu. The efficacy and safety of scleral lenses in treating severe ocular surface disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 149-154. |
| [2] | BI Zhaojing, LI Yuanbin. Current status of experimental models and applications of meibomian gland dysfunction [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 159-165. |
| [3] | DUAN Lian, MENG FanlanReview,DANG GuangfuGuidance. Effect of dry eye on refractive cataract surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 1-6. |
| [4] | LI YansongOverview,ZHU YuguangGuidance. Research progress on the effects of tear film stability on visual quality after phacoemulsification [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(6): 19-25. |
| [5] | Huang Tianze, Chen Di,LI Ying. Advances of machine learning in the diagnosis of ocular surface diseases and guiding corneal surgical procedures [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(6): 13-19. |
| [6] | LI Wei, ZHANG Bin. Effects of optimal pulse technology combined with meibomian gland massage to treat meibomian gland dysfunction [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(2): 105-109. |
| [7] | LI Shang, ZHANG Wei, LU Hongshuang, ZANG Yunxiao, DONG Hongwei, GUO Chungang, PAN Zhiqiang, JIE Ying. Clinical observations following thermal pulsation system treatment for mild and moderate meibomian gland dysfunction [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 91-95. |
| [8] | LIU Zhao, WU Changrui, GAO Ning. Evaluation of meibomian gland dysfunction after phacoemulsification surgery [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(6): 68-70. |
|